← back to search

Richard M. Cubbon

University of Leeds · GB
Area of research
Cardiology and Cardiovascular Medicine · Molecular Biology
Research interest
Research interests include Cardiovascular Function and Risk Factors, Heart Failure Treatment and Management, Angiogenesis and VEGF in Cancer, and Nitric Oxide and Endothelin Effects.
h-index
43
citations
7,818
works
289
NIH funding
primary concept
email

Recent publications

PIEZO Force Sensors and the Heart.
2026cited by 5position: contributordoi
Cardiovascular involvement in glycogen storage diseases.
2026cited by 0position: contributordoi
Analysis of the diabetic arterial transcriptome to define novel biomarkers of macrovascular disease
2026cited by 0position: contributordoi
Prevalence and incidence of left ventricular systolic dysfunction and adverse outcomes in patients receiving <i>de novo</i> and replacement pacemaker therapy for bradycardia
European Heart Journal Open 2026cited by 0position: contributordoi
Characterisation of diabetes-associated adipose tissue dysfunction across the spectrum of body mass index
2026cited by 0position: contributordoi
&lt;i&gt;PIEZO1&lt;/i&gt; variant implications for biological understanding and human health.
2025cited by 7position: contributordoi
Application of CIBERSORTx and BayesPrism to deconvolution of bulk RNA-seq data from human myocardium and skeletal muscle.
2025cited by 4position: contributordoi
Endothelial insulin-like growth factor-1 signalling regulates vascular barrier function and atherogenesis.
2025cited by 3position: contributordoi
Paracrine role of endothelial IGF-1 receptor in depot-specific adipose tissue adaptation in male mice.
2025cited by 3position: contributordoi
Comorbidity trajectories before and after the diagnosis of heart failure: A UK Biobank cohort study.
2025cited by 2position: contributordoi
Infection in people with heart failure: an overlooked cause of adverse outcomes.
2025cited by 1position: contributordoi
Assessing LV Contractility Identifies Populations With Preserved Ejection Fraction at Risk of Adverse Heart Failure Outcomes.
2025cited by 1position: contributordoi
Navigating UK cardiology higher specialty training applications: a practical guide.
2025cited by 0position: contributordoi
Clinical and cardiovascular magnetic resonance factors associated with elevated neutrophil-to-lymphocyte ratio in patients with heart failure: an analysis of a single-centre, prospective registry.
2025cited by 0position: contributordoi
Widening gap in life expectancy between patients with heart failure living in most and least deprived areas: a longitudinal cohort study.
2025cited by 0position: contributordoi
Murine limb ischaemia induces structural and functional remodelling of local and distant bone marrow
Biochemical and Biophysical Research Communications 2025cited by 0position: contributordoi
Murine limb ischaemia induces structural and functional remodelling of local and distant bone marrow
2025cited by 0position: contributordoi
Advancing the access to cardiovascular diagnosis and treatment among women with cardiovascular disease: a joint British Cardiovascular Societies’ consensus document
Heart 2024cited by 36position: middledoi
Advancing the access to cardiovascular diagnosis and treatment among women with cardiovascular disease: a joint British Cardiovascular Societies' consensus document.
2024cited by 22position: contributordoi
The diabetic myocardial transcriptome reveals Erbb3 and Hspa2 as a novel biomarkers of incident heart failure.
2024cited by 3position: contributordoi
Inflammation, infection, and cardiovascular risk.
2024cited by 2position: contributordoi
Diabetes mellitus does not alter mortality or hospitalisation risk in patients with newly diagnosed heart failure with preserved ejection fraction: Time to rethink pathophysiological models of disease progression.
2024cited by 2position: contributordoi
Small molecule modulation of insulin receptor-insulin like growth factor-1 receptor heterodimers in human endothelial cells.
2024cited by 1position: contributordoi
Echocardiographic screening for heart failure and optimization of the care pathway for individuals with pacemakers: a randomized controlled trial.
2024cited by 1position: contributordoi
Insulin receptor signalling in PDGFRβ-expressing cells influences systemic metabolism and negatively impacts lipid storage.
2024cited by 0position: contributordoi
Comorbidity trajectories before and after the diagnosis of heart failure: a UK Biobank cohort study
2024cited by 0position: contributordoi
Distinct, common and synergistic effects of insulin and IGF-1 receptors on healthy murine ageing.
2024cited by 0position: contributordoi
Small molecule modulation of insulin receptor-insulin like growth factor-1 receptor heterodimers in human endothelial cells
2024cited by 0position: contributordoi
Studying Adipose Endothelial Cell/Adipocyte Cross-Talk in Human Subcutaneous Adipose Tissue.
2024cited by 0position: contributordoi
The diabetic myocardial transcriptome reveals Erbb3 as a novel biomarker of incident heart failure
2024cited by 0position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Mark T. Kearney · University of Leeds66 papers (2012–2025) · 50 papers (2020–2026)Klaus K. Witte · University of Leeds34 papers (2019–2026) · 21 papers (2020–2026)David J. Beech · University of Leeds15 papers (2020–2026) · 11 papers (2019–2026) · 11 papers (2020–2025)Peter Swoboda · University of Leeds10 papers (2020–2025)Patrick Lillie · Castle Hill Hospital9 papers (2020–2025)Stephen B. Wheatcroft · Leeds General Infirmary9 papers (2012–2024) · 8 papers (2020–2026) · 8 papers (2020–2026) · 8 papers (2020–2024)Ann W Morgan · University of Leeds8 papers (2020–2024) · 7 papers (2021–2026) · 6 papers (2022–2025)Maria F Paton · Leeds Teaching Hospitals NHS Trust5 papers (2020–2026) · 5 papers (2021–2025)Natalie J. Haywood · University of Leeds5 papers (2020–2025)Nadira Y. Yuldasheva · University of Leeds4 papers (2021–2025)